Alexander Martens Selected Research

Therapeutics

5/2019

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Martens Research Topics

Disease

15	Melanoma (Melanoma, Malignant) 01/2023 - 01/2014
5	Neoplasm Metastasis (Metastasis) 04/2017 - 03/2014
2	Infections 01/2022 - 01/2021
1	Central Nervous System Infections (Central Nervous System Infection) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Bacterial Meningitis 01/2021
1	Bacteremia 01/2020
1	Neoplasms (Cancer) 12/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
5	IpilimumabIBA 04/2017 - 01/2016
3	AntigensIBA 01/2015 - 01/2014
3	MART-1 AntigenIBA 01/2015 - 03/2014
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2019 - 12/2016
2	Interleukin-2 (IL2)IBA 04/2017 - 07/2014
2	HLA-DR Antigens (HLA-DR)IBA 03/2014 - 01/2014
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 05/2019
1	Growth Differentiation Factor 15IBA 12/2016
1	pembrolizumabIBA 11/2016
1	Interleukin-4 (Interleukin 4)IBA 08/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2014

Therapy/Procedure

1	Therapeutics 05/2019
1	Injections 07/2014
1	Intralesional Injections 07/2014